Carasent ASA (CARAC)

Currency in NOK
21.10
0.00(0.00%)
Closed·

CARAC Earnings

Latest Release
Jul 10, 2026
EPS / Forecast
-0.04 / --
Revenue / Forecast
97.71M / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2026-0.040/--97.71M/------Free Sign Up
03/20260.040/--90.41M/------Free Sign Up
12/20250.420/--93.57M/------Free Sign Up
09/20250.200/0.17082.20M/77.00M+17.65%+6.75%Free Sign Up
06/2025-0.080/0.14082.87M/79.00M-157.14%+4.9%Free Sign Up
03/2025-0.040/0.10085.18M/77.00M-140%+10.62%Free Sign Up
12/2024-0.040/0.03785.18M/45.04M-208.7%+89.12%Free Sign Up
09/2024-0.030/-0.00565.36M/37.65M-552.17%+73.6%Free Sign Up
06/20240.010/0.00066.14M/66.00M--+0.21%Free Sign Up
03/20240.010/0.01067.00M/67.00M0%0%Free Sign Up

All numbers in SEK

Carasent ASA Earnings Call Summary for Q3/2026

  • Q3 revenue rose 12% organically to SEK 108M; EBITDA margin expanded to 20% from 15%, reflecting stronger operating leverage and profitability.
  • Contracted ARR reached SEK 424M with 14% organic growth; net retention hit 110% as Nordic business grew 15% while Germany continued to lag.
  • AI tool Medsum reached 300 paying users; expanded features launching Christmas 2024 to automate patient documentation and administrative workflows.
  • Q4 margins expected to compress due to SEK 2-3M MDR certification costs and SEK 3-4M Germany sales push, plus tougher year-over-year comparisons.
  • Shares rose 3.9% to $21.1, near 52-week high of $21.3; management investing in Germany expansion with new CEO and modernizing legacy Data-AL product.
Last Updated: 10/15/2026, 03:06 PM
Read Full Transcript
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.